Gilead Sciences (GILD)Sen. Alan Armstrong disclosed a purchase $1K–$15K

$1,001–$15,000

Reported range · official band, not an exact amount

116 days

Disclosure lag

Traded

Mar 27, 2026

Disclosed

Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 23, 2026InsiderCEO sold ~$15.6M of GILD shares in the open market
2. Jan 27, 2026CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
3. Jan 28, 2026Insider · 1 personInsiders: 2 sales (~$1.4M)
4. Feb 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.3%
5. Feb 5, 2026InsiderCEO sold ~$17.3M of GILD shares in the open market
6. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
7. Feb 17, 2026Insider · 2 peopleInsiders: 4 sales (~$4.8M)
8. Feb 22, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
9. Feb 27, 2026Insider · 1 personInsiders: 3 sales (~$1.4M)
10. Mar 16, 2026Insider · 2 peopleInsiders: 2 sales (~$865K)
11. Mar 25, 2026Layoff notice · 333 Lakeside Drive San Mateo CA 94404Layoff notice filed in CA: 51 employees
12. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
13. Mar 27, 2026 · this disclosureCongressDisclosed purchase of GILD — reported range $1,001 - $15,000

What came next

1. Mar 27, 2026InsiderCEO sold ~$1.37M of GILD shares in the open market
2. Apr 15, 2026Insider · 2 peopleInsiders: 2 sales (~$846K)
3. Apr 28, 2026Insider · 1 personInsiders: 2 sales (~$1.3M)
4. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
5. Apr 30, 2026Layoff notice · 800 Bridge Parkway Redwood City CA 94065Layoff notice filed in CA: 108 employees
6. May 6, 2026Congress · 1 personMembers of Congress: 2 purchases
7. May 7, 2026Company filing · Form 8-K · ResultsReported its results
8. May 14, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
9. May 15, 2026Insider · 2 peopleInsiders: 5 sales (~$4.1M)
10. May 22, 2026FDAFDA drug approval: Hepcludex
11. May 22, 2026Government · Federal Register noticeNotice of Decision Not To Designate Hepatitis Delta Virus Diseases as an Addition to the Current List of Tropical Diseases in the Federal Food, Drug, and Cosmetic Act
12. Jun 1, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
13. Jun 15, 2026Insider · 2 peopleInsiders: 4 sales (~$748K)
14. Jun 24, 2026FDAFDA drug approval: Trodelvy
15. Jun 24, 2026FDAFDA drug approval: Trodelvy
16. Jul 1, 2026Insider · 1 personInsiders: 2 sales (~$1.9M)
17. Jul 15, 2026Insider · 2 peopleInsiders: 2 sales (~$780K)

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Gilead Sciences

For Gilead Sciences, OQRO holds 28 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 78 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.

Other recent filings by Sen. Alan Armstrong

• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
• Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
• Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
• Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Gilead Sciences

• SEC Form 4Oct 3, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Sep 16, 2026

Everything OQRO holds on this company is on its GILD page.